DRUG GUIDELINE

Vasopressin (Argipressin) Intravenous Infusion
SCOPE (Area): Emergency, ICU, Theatre, (Exclude: Paediatrics Seek Advice), (Exclude: General Wards), Cardiovascular Suite, (Exclude: Coronary Care Unit)
SCOPE (Staff): Medical, Nursing, Pharmacy
Printed versions of this document SHOULD NOT be considered up to date / current


Exclusions

Paediatrics (seek Paediatrician advice)


Preamble

See Appendix for full version of this Drug Guideline!


Related Documents

CPP0222 - User Applied Labelling Of Injectable Medicines, Fluids And Lines
CPP0544 - Intravenous Drug Administration And Classification List
POL0077 - Medication Management
CPP0473 - Alaris Intravenous Infusion System With Guardrails Medication And Fluid Management Software
SOP0001 - Principles Of Clinical Care


References

Alfred Hospital. (2018, May). Argipressin (Vasopressin) Infusion Drug Guideline. Alfred Hospital. Accessed from Prompt Guidelines via Victag August 19, 2018.
Australian Transplant Coordinators Association Incorporated. (2008). National Guidelines for Organ and Tissue Donation (4th ed.). Australian Transplant Coordinators Association Incorporated.
Barwon Health. (2017, February). Argipressin (Vasopressin) Drug Protocol. Barwon Health. Accessed from Prompt Guidelines via Victag August 19, 2018.
Bendigo Health. (2010, August). Vasopressin Drug Protocol. Bendigo Health. Accessed from Prompt Guidelines via Victag August 19, 2018.
Forrest, P. (No date). Vasopressin and Shock. Retrieved March 26, 2012
IBM Corporation. (2018). IBM Micromedex. Retrieved August 19, 2018, from
Medscape. (No date). Medscape Critical Care: SAFE, VASST, LIPOS Trial 3, CORTICUS and more: Implications for the Surviving Sepsis Campaign Guidelines. Retrieved March 21, 2012
MIMS Australia. (2019, April). MIMS Online, Pitressin® product information. Retrieved April 22, 2019, from
Monash Health. (2017, October). Argipressin (Vasopressin) Adult Medication Profile. Monash Health. Accessed from Prompt Guidelines via Victag August 19, 2018.
Peninsula Health. (2017, July). Vasopressin (Argipressin) Adult Drug Administration Guideline. Peninsula Health. Accessed from Prompt Guidelines via Victag August 19, 2018.
Rossi, S. (2019, January). Australian Medicines Handbook. Retrieved April 22, 2019, from
Russell J et al. Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock. NEJM. 2008;358(9):877-887.
Safer Care Victoria. (2018, December). Vasopressin (argipressin) guideline. Retrieved April 13, 2019, from
The Society of Hospital Pharmacists of Australia. 2019. Australian Injectable Drugs Handbook (7th ed.). Retrieved August 22, 2019, from
UpToDate, Inc. (2019) UpToDate, Drug Interaction section. Retrieved April 22, 2019, from


Appendix

Appendix 1 - Vasopressin (Argipressin) - intravenous infusion



Reg Authority: Medication Safety & Governance Committee (MSGC) Date Effective: 30/09/2020
Review Responsibility: Pharmacist - Rotational Date for Review: 30/09/2024
Vasopressin (Argipressin) Intravenous Infusion - DRG0041 - Version: 5 - (Generated On: 17-06-2025 05:55)